For Research Use Only. Not for Human Consumption. Not for use in diagnostic or therapeutic procedures. This product has not been evaluated by the FDA for safety or efficacy. Sold for laboratory research purposes only.
CAS: 946870-92-4 · MW: ~9111 Da · Purity: ≥99% by reverse-phase HPLC · Format: 1 mg powder · Identity: ESI-MS confirmed
IGF-1 LR3 is a longer-lasting laboratory version of insulin-like growth factor 1, a protein central to growth and tissue signaling. The “LR3” modifications make it more stable and change how it interacts with the proteins that normally bind and limit natural IGF-1, so it stays active longer in an experiment. This is the 1 mg vial, supplied for growth-factor research.
IGF-1 LR3 (Long-R3 IGF-1) is an 83-amino-acid recombinant analog of human IGF-1. It carries two key changes: an arginine substitution at position 3 and a 13-residue extension on the N-terminus. Those modifications reduce its binding to IGF-binding proteins and extend its activity, which is the whole point of the analog. Its molecular weight is roughly 9111 Da.
IGF-1 LR3 research follows the biology of IGF-1 signaling.
These are research contexts, not approved uses, and the peptide is intended for laboratory study.
| Attribute | Value |
| Chemical name | IGF-1 LR3 |
| Also Known As | Long-R3 IGF-1 |
| Modifications | Arg³ substitution + 13-residue N-terminal extension |
| Length | 83 amino acids |
| CAS number | 946870-92-4 |
| Molecular weight | ~9111 g/mol |
| Purity | ≥99% by reverse-phase HPLC |
| Length | 83 amino acids |
| Identity | Confirmed by ESI mass spectrometry |
| Physical form | Lyophilized powder |
| Appearance | White to off-white solid |
| Quantity | 1 mg per vial |
| Storage | -20°C, protected from light |
| Solubility | Soluble in dilute acetic acid or sterile water (gentle mixing) |
| Classification | Research use only |
Keep the sealed vial frozen at -20°C and shielded from light until use. After reconstitution, store the solution at 2-8°C and use it within about two weeks. Because IGF-1 LR3 is a larger, folded protein, gentle reconstitution matters: swirl rather than shake, let it dissolve fully, and avoid repeated freeze-thaw cycles.
IGF-1 LR3 is produced under research-grade manufacturing controls and verified by an independent lab before release. Purity is measured by reverse-phase HPLC and identity by mass spectrometry, with testing carried out by third-party laboratories, including Janoshik Analytical and domestic US labs. A certificate of analysis is published for each batch, so the results trace to your material.
IGF-1 LR3 is a long-acting recombinant analog of insulin-like growth factor 1, an 83-amino-acid protein. It is studied in growth-factor signaling research and is supplied for research use only.
“Long-R3” refers to the two modifications: a 13-residue N-terminal extension (“Long”) and an arginine substitution at position 3 (“R3”). Together they extend the analog’s active life.
The LR3 modifications reduce its binding to IGF-binding proteins that normally limit IGF-1, so LR3 stays active longer in an experiment than the unmodified protein.
It is an 83-amino-acid protein with a molecular weight around 9111 Da and CAS number 946870-92-4.
No, IGF-1 LR3 is not FDA approved. It is a research-use-only material and is not intended for human or veterinary use.
IGF-1 LR3 is a potent, larger protein typically studied at small quantities, so it is offered in a 1 mg vial. The amount refers to the protein content.
Keep the powder frozen at -20°C and protected from light. Once reconstituted for research, store at 2-8°C and use within about two weeks.
It is tested to ≥99% purity by reverse-phase HPLC with mass-spec identity confirmation by an independent lab, and each batch has a published certificate of analysis.
$169.00
6 in stock
For Research Use Only. Not for Human Consumption. Not for use in diagnostic or therapeutic procedures. This product has not been evaluated by the FDA for safety or efficacy. Sold for laboratory research purposes only.
CAS: 946870-92-4 · MW: ~9111 Da · Purity: ≥99% by reverse-phase HPLC · Format: 1 mg powder · Identity: ESI-MS confirmed
IGF-1 LR3 is a longer-lasting laboratory version of insulin-like growth factor 1, a protein central to growth and tissue signaling. The “LR3” modifications make it more stable and change how it interacts with the proteins that normally bind and limit natural IGF-1, so it stays active longer in an experiment. This is the 1 mg vial, supplied for growth-factor research.
IGF-1 LR3 (Long-R3 IGF-1) is an 83-amino-acid recombinant analog of human IGF-1. It carries two key changes: an arginine substitution at position 3 and a 13-residue extension on the N-terminus. Those modifications reduce its binding to IGF-binding proteins and extend its activity, which is the whole point of the analog. Its molecular weight is roughly 9111 Da.
IGF-1 LR3 research follows the biology of IGF-1 signaling.
These are research contexts, not approved uses, and the peptide is intended for laboratory study.
| Attribute | Value |
| Chemical name | IGF-1 LR3 |
| Also Known As | Long-R3 IGF-1 |
| Modifications | Arg³ substitution + 13-residue N-terminal extension |
| Length | 83 amino acids |
| CAS number | 946870-92-4 |
| Molecular weight | ~9111 g/mol |
| Purity | ≥99% by reverse-phase HPLC |
| Length | 83 amino acids |
| Identity | Confirmed by ESI mass spectrometry |
| Physical form | Lyophilized powder |
| Appearance | White to off-white solid |
| Quantity | 1 mg per vial |
| Storage | -20°C, protected from light |
| Solubility | Soluble in dilute acetic acid or sterile water (gentle mixing) |
| Classification | Research use only |
Keep the sealed vial frozen at -20°C and shielded from light until use. After reconstitution, store the solution at 2-8°C and use it within about two weeks. Because IGF-1 LR3 is a larger, folded protein, gentle reconstitution matters: swirl rather than shake, let it dissolve fully, and avoid repeated freeze-thaw cycles.
IGF-1 LR3 is produced under research-grade manufacturing controls and verified by an independent lab before release. Purity is measured by reverse-phase HPLC and identity by mass spectrometry, with testing carried out by third-party laboratories, including Janoshik Analytical and domestic US labs. A certificate of analysis is published for each batch, so the results trace to your material.
IGF-1 LR3 is a long-acting recombinant analog of insulin-like growth factor 1, an 83-amino-acid protein. It is studied in growth-factor signaling research and is supplied for research use only.
“Long-R3” refers to the two modifications: a 13-residue N-terminal extension (“Long”) and an arginine substitution at position 3 (“R3”). Together they extend the analog’s active life.
The LR3 modifications reduce its binding to IGF-binding proteins that normally limit IGF-1, so LR3 stays active longer in an experiment than the unmodified protein.
It is an 83-amino-acid protein with a molecular weight around 9111 Da and CAS number 946870-92-4.
No, IGF-1 LR3 is not FDA approved. It is a research-use-only material and is not intended for human or veterinary use.
IGF-1 LR3 is a potent, larger protein typically studied at small quantities, so it is offered in a 1 mg vial. The amount refers to the protein content.
Keep the powder frozen at -20°C and protected from light. Once reconstituted for research, store at 2-8°C and use within about two weeks.
It is tested to ≥99% purity by reverse-phase HPLC with mass-spec identity confirmation by an independent lab, and each batch has a published certificate of analysis.

The VIP Peptide (Vasoactive Intestinal Peptide) is a naturally occurring neur...
$72.00Save 20% on 10+COA Available
Purchase & earn 72 points.Add to cart
CAS: 863288-34-0 · MW: 3367.9 Da · Purity: ≥99% by reverse-phase HPLC · Forma...
$38.00Save 20% on 10+COA Available
Purchase & earn 38 points.Add to cart
Format: 30 mL sterile solution · Composition: sterile water + 0.9% benzyl alc...
$12.00Save 20% on 10+COA Available
Purchase & earn 12 points.Add to cart99%+ purity. third-party verified. both 3rd party domestic Labs And Janoshik Analytical Verified.
$169.00
/vial
LifeLinkResearch.com
We use cookies to enhance your experience. By continuing to use our site, you consent to our cookie policy.
By using this site, you confirm you have read our waiver and agree to all terms of our disclaimer of liability.
By clicking Agree, you accept these terms and conditions.
Please tick the box above to continue.